Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

    Investing

    • Inheritance TaxInheritance Tax
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Client Area and Conectus Portal
  • Contact Us

Market News - Page 280

7 June 2022

Pearson PLC Sale of Local K12 Courseware Businesses in Italy and Germany

Today, Pearson announces that it has agreed to sell its local K12 Courseware businesses in Italy and Germany to Sanoma Corporation, a leading European K12 learning services company operating in 11 countries and listed in Nasdaq Helsinki (SAA1V). …

7 June 2022

Ted Baker plc Update on Formal Sale Process

The Board of Ted Baker PLC (“Ted Baker” or the “Company”) announces an update on its formal sale process….

7 June 2022

Biffa plc Announcement Regarding Possible Offer

The Board of Biffa plc (“Biffa” or the “Company”) announces that it has received a series of unsolicited and indicative proposals from affiliates of Energy Capital Partners, LLC (“ECP”) on behalf of funds and other investment vehicles managed and/or advised by ECP and its affiliates to acquire the entire issued, and to be issued, share capital of the Company….

6 June 2022

Melrose Industries plc Sale of Ergotron

Melrose Industries PLC (“Melrose”, the “Company” or the “Group”) has entered into an agreement to sell its Ergotron business (“Ergotron”), to funds managed by The Sterling Group….

6 June 2022

AstraZeneca plc Anhertu Efficacy Results in HER2-Low Breast Cancer

Enhertu reduced the risk of disease progression or death by 50% vs. chemotherapy in patients with HER2-low metastatic breast cancer with HR-positive and HR-negative disease…

6 June 2022

GlaxoSmithKline US FDA Approval of Priorix

GSK announces US FDA approval of Priorix for the prevention of measles, mumps and rubella in individuals 12 months of age and older…

1 June 2022

GSK PLC GSK to acquire Affinivax, Inc.

GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc….

1 June 2022

Johnson Matthey PLC – Completion of Health sale

Johnson Matthey Plc (JM), a global leader in sustainable technologies, today announces that that it has completed the sale of its Health business in accordance with the terms of the sale agreement entered into between JM and Altaris Capital Partners (“Altaris”), a leading healthcare investment firm….

Posts navigation

  • «
  • 1
  • …
  • 278
  • 279
  • 280
  • 281
  • 282
  • …
  • 858
  • »

Home > Market News > Page 280

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Client Area and Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© Copyright 2010-2025. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG